# Phase II Study of Albumin Bound Paclitaxel With 5-FU and CF as Second Line in Taxanes Naive Advanced Gastric Cancer

> **NCT02229045** · PHASE2 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 37 (estimated)

## Conditions studied

- Gastric Caner

## Interventions

- **DRUG:** Albumin Bound Paclitaxel
- **DRUG:** 5-FU

## Key facts

- **NCT ID:** NCT02229045
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-11
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 37 (ESTIMATED)
- **Last updated:** 2014-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02229045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02229045, "Phase II Study of Albumin Bound Paclitaxel With 5-FU and CF as Second Line in Taxanes Naive Advanced Gastric Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02229045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*